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wTATE-OF-THE-ART PAPER1Positron Emission Tomographyrank M. Bengel, Takahiro Higuchi, Mehrbod S. Javadi, Riikka Lautamäki
ositron emission tomography (PET) is a powerful, quantitative imaging modality that has
een used for decades to noninvasively investigate cardiovascular biology and physiology. Due
o limited availability, methodological complexity, and high costs, it has long been seen as a
esearch tool. However, Bengel and colleagues argue that this is beginning to change. This
hange is partly due to both methodological advances and improved radiotracer availability,
nd to increased recognition that the information is clinically useful. PET appears poised to
lay an important role in the future with comprehensive, personalized cardiovascular
edicine.NEWS FROM THE NCDR EWS FROM THE NCDR16Similar Outcomes for PCI at Centers With or Without On-Site Cardiac Surgeryichael A. Kutcher, Lloyd W. Klein, Fang-Shu Ou, Thomas P. Wharton, Jr, Gregory J. Dehmer,
andeep Singh, H. Vernon Anderson, John S. Rumsfeld, William S. Weintraub, Richard E. Shaw,
atthew T. Sacrinty, Albert Woodward, Eric D. Peterson, Ralph G. Brindis, on behalf of the
ational Cardiovascular Data Registry
he infrequent need for emergency cardiac surgery after percutaneous coronary intervention
PCI) and the efficacy of primary PCI compared with fibrinolytic therapy have led some
ospitals without on-site cardiac surgery to develop PCI programs. Kutcher and colleagues
ompiled data collected from the National Cardiovascular Data Registry (NCDR) and
ompared outcomes for procedures done in facilities with or without on-site cardiac surgery.
ff-site PCI facilities had similar observed rates of success, total complications, emergency
ardiac surgery, and mortality with emergency surgery. There were no differences in risk-
djusted outcomes for in-hospital mortality or overall mortality. These data suggest that, for
atients treated, NCDR PCI facilities without cardiac surgery on-site were as safe as those
ith on-site surgical capabilities.(continued on page A-17)
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oORONARY ARTERY DISEASE25Cardiac Rehabilitation Shows Mortality Benefit in a Broad PopulationEditorial Comment
Therese A. Stukel,ose A. Suaya, William B. Stason, Philip A. Ades, Sharon-Lise T. Normand, Donald S. Shepard
andomized controlled trials and meta-analyses have shown that cardiac rehabilitation (CR)
mproves survival in select patients, but the generalizability of this has been questioned. Suaya
nd colleagues queried the Medicare database to find over 600,000 people who were
ospitalized for a coronary condition. Subjects who had a subsequent claim for CR were
ompared with those who did not attend CR. CR users and nonusers were matched using a
ariety of techniques. All 3 matching techniques showed significantly lower 1- and 5-year
ortality rates in CR users than in nonusers, with relative reductions ranging from 21% to
4%. Mortality reductions were seen in all demographic and clinical subgroups. These results
uggest that CR improves mortality across a broad spectrum of cardiac patients.EART FAILURE
36idespread Abnormalities in Systolic and Diastolic Function
in Patients With HFNEFEditorial Commentu Ting Tan, Frauke Wenzelburger, Eveline Lee, Grant Heatlie, Francisco Leyva, Kiran Patel,
ichael Frenneaux, John E. Sanderson
an and colleagues studied the pathophysiology of patients with heart failure and normal
jection fraction (HFNEF). Subjects with HFNEF were compared with healthy controls with
series of echocardiographic measurements both at rest and with exertion. At rest, systolic
ongitudinal and radial strain, systolic mitral annular velocities, and apical rotation were lower
n patients with HFNEF and all failed to rise normally during exercise. In diastole, HFNEF
atients had reduced and delayed untwisting, reduced left ventricular suction at rest and on
xercise, and higher end-diastolic pressures. In HFNEF, there are widespread abnormalities
f both systolic and diastolic function that become more apparent on exercise.(continued on page A-22)
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rARDIAC IMAGING49Characteristics of Vulnerable Plaques on CT AngiographyEditorial Commentadako Motoyama, Masayoshi Sarai, Hiroto Harigaya, Hirofumi Anno, Kaori Inoue, Tomonori Hara,
iroyuki Naruse, Junichi Ishii, Hitoshi Hishida, Nathan D. Wong, Renu Virmani, Takeshi Kondo,
ukio Ozaki, Jagat Narula
otoyama and colleagues prospectively followed more than 1,000 patients who had
ndergone a computed tomographic (CT) angiography study to determine which
therosclerotic lesions were more likely to rupture and lead to subsequent acute coronary
yndrome (ACS). Both positive remodeling (PR) of the vessel wall and low attenuation of the
laques (LAP) were studied as potential risk factors based on intravascular ultrasound studies
f culprit lesions. Of the 45 plaques with both PR and LAP, 22% resulted in subsequent
CS, compared with 4% of the plaques with only 1 of the features and 0.5% of plaques with
either PR nor LAP. Patients with PR and LAP on CT angiography are at a high risk of
eveloping ACS over the next 2 years.IOMARKERS60Copeptin May Improve the Accuracy and Speed of Chest Pain Assessmentsobias Reichlin, Willibald Hochholzer, Claudia Stelzig, Kirsten Laule, Heike Freidank, Nils G. Morgenthaler,
ndreas Bergmann, Mihael Potocki, Markus Noveanu, Tobias Breidthardt, Andreas Christ,
ujana Boldanova, Ramona Merki, Nora Schaub, Roland Bingisser, Michael Christ, Christian Mueller
opeptin, the C-terminal part of the vasopressin prohormone, is a marker of endogenous
tress that is elevated in patients after acute myocardial infarction (AMI). Reichlin and
olleages measured copeptin and troponin T levels in almost 500 consecutive patients
resenting to the emergency department with symptoms suggestive of AMI. A copeptin level
14 pmol/l in combination with a troponin T 0.01 g/l correctly ruled out AMI with a
ensitivity of 99%, a negative predictive value of 99.7%, and a positive predictive value of
6%. In other words, AMI was correctly excluded with only 1 blood draw in 65% of patients.
f the remaining patients with positive results for either copeptin, troponin T, or both,
oughly one-half of patients received a final diagnosis of AMI.
